Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel in Platinum Refractory Ovarian Cancer
NCT01747239Phase 2Terminated
- Sponsor
- Vejle Hospital
- Start
- Jan 2013
- Primary completion
- Jul 2014
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel ginsenoside liposome injection in ovarian cancer, sponsored by Vejle Hospital. Started Jan 2013; status: terminated.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT01747239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01747239.